Krepler Katharina, Biowski Robert, Schrey Susanne, Jandrasits Kerstin, Wedrich Andreas
Department of Ophthalmology, University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):735-8. doi: 10.1007/s00417-002-0530-7. Epub 2002 Aug 21.
Compared to non-diabetic patients, outcome after cataract surgery was reported to be worse in diabetic patients--especially in those with diabetic retinopathy. This prospective study was planned to evaluate visual outcome, progression of diabetic retinopathy, and incidence of clinically significant macular oedema (CSME) in a homogenous group of patients with non-proliferative diabetic retinopathy (NPDR) without CSME at baseline 1 year after cataract surgery.
Over a period of 18 months, all consecutive patients with mild-to-moderate diabetic retinopathy who had cataract surgery with phacoemulsification and posterior chamber lens implantation were prospectively followed up. Outcomes were assessed 1 year postoperatively and included visual acuity (VA), progression of retinopathy, and incidence of CSME. Progression of retinopathy and incidence of CSME were compared to the non-operated fellow eyes.
Of 50 patients included, 42 completed the 1-year follow-up. VA improved in 85% of patients, and was better than 0,5 in 71%. Progression of retinopathy occurred in 12% of eyes after cataract surgery and in 10.8% of non-operated fellow eyes. No patient developed proliferative diabetic retinopathy in the operated eye. CSME occurred in 13 operated eyes (31%), five of them with retinal ischemia, and in five non-operated eyes (13.5%). Patients with ischemic macular oedema had the worst prognosis regarding VA.
Modern cataract surgery seems to have no influence on the progression of diabetic retinopathy. A visual improvement is achieved in the majority of patients with NPDR, but poorer visual outcome is observed in patients developing macular oedema.
与非糖尿病患者相比,据报道糖尿病患者白内障手术后的预后较差,尤其是患有糖尿病视网膜病变的患者。本前瞻性研究旨在评估白内障手术后1年时,一组基线时无临床显著性黄斑水肿(CSME)的非增殖性糖尿病视网膜病变(NPDR)患者的视力预后、糖尿病视网膜病变的进展情况以及CSME的发生率。
在18个月的时间里,对所有接受白内障超声乳化吸除联合后房型人工晶状体植入术的轻至中度糖尿病视网膜病变患者进行前瞻性随访。术后1年评估结果,包括视力(VA)、视网膜病变进展情况以及CSME的发生率。将视网膜病变进展情况和CSME的发生率与未手术的对侧眼进行比较。
纳入的50例患者中,42例完成了1年的随访。85%的患者视力得到改善,71%的患者视力优于0.5。白内障手术后12%的患眼出现视网膜病变进展,未手术的对侧眼中10.8%出现进展。手术眼未出现增殖性糖尿病视网膜病变患者。13只手术眼(31%)发生了CSME,其中5只伴有视网膜缺血,5只未手术眼(13.5%)发生了CSME。缺血性黄斑水肿患者的视力预后最差。
现代白内障手术似乎对糖尿病视网膜病变的进展没有影响。大多数NPDR患者视力得到改善,但发生黄斑水肿的患者视力预后较差。